NCT05802797 is a EARLY_PHASE1 clinical trial of Algae Oil Fortified Soymilk in Healthy Diet, sponsored by Ohio State University Comprehensive Cancer Center.

Who is sponsoring NCT05802797?

NCT05802797 is sponsored by Ohio State University Comprehensive Cancer Center.

What drugs are being tested in NCT05802797?

Interventions in NCT05802797: Algae Oil Fortified Soymilk, Algae Oil Capsule.

What condition does NCT05802797 study?

NCT05802797 studies Healthy Diet.

Is NCT05802797 still recruiting?

NCT05802797 is currently active, enrolled. Last updated 21 August 2025.

Last reviewed 2025-08-21 · How we verify

NCT05802797

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bioavailability and Pharmacodynamics of EPA and DHA From Fortified Soymilk and Capsules

Active, enrolled EARLY_PHASE1 Last updated 21 August 2025

What this trial tests

EARLY_PHASE1 trial testing Algae Oil Fortified Soymilk in Healthy Diet in 24 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

3 April 2023

Primary endpoint
10 July 2026

10 July 2026

Quick facts

Lead sponsor	Ohio State University Comprehensive Cancer Center
Phase	EARLY_PHASE1
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	basic science
Enrollment	24
Start date	3 April 2023
Primary completion	10 July 2026
Estimated completion	10 July 2026
Sites	1 location across United States

Drugs / interventions tested

Algae Oil Fortified Soymilk
Algae Oil Capsule

Conditions studied

Healthy Diet — all drugs for Healthy Diet →

Sponsor

Ohio State University Comprehensive Cancer Center

Who can join

Adults 18 to 60, any sex, with Healthy Diet. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will compare the algae oil fortified soymilk to a commercial algae oil capsule containing the same base oil with the goal of demonstrating equivalent or greater accumulation of EPA and DHA in blood lipid pools.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Algae-Derived Bioactive Compounds as Platforms for Translational Biotechnology and Health Applications.
Morris H, Coombes Z, El Dor Z, Rodrigues VJ, et al · · 2026 · PMID 42200944 · DOI 10.3390/biotech15020034

Verify or expand the search:

Other recruiting trials for Healthy Diet

Currently open trials in the same condition.

NCT04119791 — A Multidisciplinary Investigation of Cardiovascular Benefits of Wild Rice · NA · recruiting
NCT05869760 — Baylor Infant and Toddler Biomarker of Nutrition Study · recruiting
NCT04079855 — Monell USDA Taste Test Study · NA · active not recruiting
NCT06698094 — Sustainable Office Intervention, Impact of a Sustainable Lifestyle on Diet, Physical Activity and Carbon Footprint · NA · active not recruiting
NCT04985630 — The Mitopure Challenge to Detect Levels of Urolithin A in Dried Blood Spots · NA · recruiting

Other Ohio State University Comprehensive Cancer Center trials

Trials by the same sponsor.

NCT06816979 — Lumbar Punctures for the Detection of ctDNA in the Cerebrospinal Fluid of Patients With Stage III and IV Non-Small Cell · NA · not yet recruiting
NCT07529483 — Endoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cysts · Phase 2 · not yet recruiting
NCT07455513 — A Novel Tobacco Cessation Resource for Smokers With a Diagnosed or Suspected Thoracic Cancer · NA · not yet recruiting
NCT07217990 — Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer · Phase 1, PHASE2 · not yet recruiting
NCT07503925 — THRIVE Study: Understanding How Oral Nicotine Pouches Affect Public Health · Phase 4 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05802797 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ohio State University Comprehensive Cancer Center
Last refreshed: 21 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05802797.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing